An international survey of thousands of eating disorder patients found that respondents rated cannabis and psychedelics, including psilocybin and LSD, as the most effective non-prescription drugs for treating their symptoms.

The survey, conducted by University of Sydney researchers and published in JAMA Network Open, found that typical prescription drugs like antidepressants were not well-regarded by respondents. Additionally, respondents said the worst non-prescribed substances for treating their symptoms included alcohol, nicotine, and cocaine, although they are still widely used.

“Our results provide important insights into the lived experiences of people with eating disorders and their drug use, highlighting promising avenues for future research into treatments,” the lead researcher, Sarah-Catherine Rodan, a PhD student at the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics, said in a press release.

“This research suggests that cannabis and psychedelics hold significant promise for improving quality of life in individuals suffering eating disorders. This is particularly salient since current pharmacological options for these patients are severely limited and current treatment outcomes so disappointing. Of course, rigorous clinical trials are needed to confirm these benefits and better determine safety profiles.” — Professor Iain McGregor, the paper’s senior author and Academic Director of the Lambert Initiative, in a statement

The survey targeted 7,600 individuals across 83 countries. About two-thirds of the respondents were formally diagnosed with an eating disorder; the others “self-reported an eating disorder that caused distress.” Additionally, all major eating disorders were represented in the study, the researchers said, including anorexia nervosa (40%), bulimia nervosa (19%), binge-eating disorder (11%), and avoidant restrictive food intake disorder (ARFID) (9%).

“I hope this study gives a voice to people living with eating disorders, revealing that their often-stigmatised experiences with drugs might in fact have therapeutic potential,” Rodan said.

The governor of Kentucky is calling on President Donald Trump to reject congressional spending bill provisions that would prevent the Justice Department from rescheduling marijuana.

In a letter sent to Trump this week, Gov. Andy Beshear (D) emphasized that a pending proposal to move cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) is something “you supported in your presidential campaign.”

“That process should be allowed to play out. Americans deserve leadership that won’t move the goalposts on them in the middle of the game,” Beshear said, noting that he was among the tens of thousands who submitted public comments in favor of the reform after it was initiated under the Biden administration, “demonstrating broad public interest in rescheduling.”

“I joined that effort because this is about helping people. Rescheduling would provide suffering patients the relief they need,” the governor said. “It would ensure communities are safer—because legal medical products reduce the illicit market. It would provide new, meaningful research on health benefits.”

Beshear also mentioned a letter to DEA he signed onto last year urging rescheduling, “because the jury is no longer out on marijuana. It has medical benefits.”

Rescheduling “is just common sense,” the governor said. “Over 40 states now have medical marijuana programs. Republicans and Democrats overwhelmingly agree on this issue, including in Kentucky, where you won a vast majority of the vote in 2016, 2020 and 2024, and where a Republican supermajority passed legislation legalizing medical marijuana in 2023—legislation that I signed into law. The federal government has fallen far behind on this issue and finally needs to catch up.”

He referenced a September 2024 comment from Trump where the then-candidate said that, under his administration, “we will continue to focus on research to unlock the medical uses of marijuana to a Schedule 3 drug, and work with Congress to pass common sense laws.”

“Now, it is time to make good on your promises to the American people.”

Referencing language included in a House committee-approved bill that would bar DOJ from rescheduling cannabis, Beshear said “this is not a common-sense law.”

“It stops a process that is already underway to accomplish a policy end that is overwhelmingly supported by the medical and scientific communities as well as the American people of every political party,” he said. “Congress should not take the decision-making process out of the hands of medical and scientific experts when they don’t like the results.”

“I hope that your action on this issue matches the promises you made to the American people to support rescheduling and work with Congress to ensure laws passed are truly ‘common sense,’” the governor said. “Again, I urge you to oppose the House Appropriations Committee’s proposed language to block the DEA from rescheduling marijuana.”

Here’s the text of the provision Beshear is asking the president to oppose: 

“SEC. 607. None of the funds appropriated or other wise made available by this Act may be used to reschedule marijuana (as such term is defined in section 102 of the Controlled Substances Act (21 U.S.C. 802)) or to remove marijuana from the schedules established under section 202 of the Controlled Substances Act (21 U.S.C. 812).”

Regardless of the appropriations bill, the rescheduling process is currently sitting in limbo—especially since the DEA judge overseeing the process has now announced he’ll be retiring at the end of the month, leaving the issue to newly confirmed DEA Administrator Terrance Cole.

Notably, while Cole has said that examining the rescheduling proposal would be “one of my first priorities” if he was confirmed for the role, he has refused to say what he wants the result to be and has in the past made comments expressing concerns about the health effects of cannabis.

In May, a Senate committee advanced the nomination of Cole to become DEA administrator amid the ongoing review of the marijuana rescheduling proposal that he has so far refused to commit to enacting.

Cole—who has previously voiced concerns about the dangers of marijuana and linked its use to higher suicide risk among youth—said in response to senators’ written questions that he would “give the matter careful consideration after consulting with appropriate personnel within the Drug Enforcement Administration, familiarizing myself with the current status of the regulatory process, and reviewing all relevant information.”

Meanwhile, earlier this month, DEA again notified DEA Administrative Law Judge John Mulrooney that the marijuana rescheduling process remains stalled under the Trump administration.

It’s been six months since Mulrooney temporarily paused hearings on a proposal to move cannabis from Schedule I to Schedule III of the CSA that was initiated under the Biden administration. And in a joint report to the judge submitted on Monday, DEA attorneys and rescheduling proponents said they’re still at an impasse.

Beshear, meanwhile, has been focused on state-level cannabis reform developments over recent years.

He recently touted “another milestone” in the state’s forthcoming medical marijuana program, with a licensed cultivator producing “the first medical cannabis inventory in Kentucky history.”

The governor previewed the development late last month, stating that he expected to see medical marijuana growers “putting seed in the ground really soon,” while projecting that patients will have access to cannabis before the year’s end.

The kids are foul mouth, opinionated, and always on point…and they love a little green plant

Since its debut in 1997, South Park has never shied away from taboo topics, and marijuana has been one of its most enduring themes. From early jokes about stoners to full-blown cannabis entrepreneurship, the evolution of weed in South Park mirrors shifting cultural attitudes—and reflects the creators’ own evolving stance.

RELATED: Why More Software Programmers Are Choosing To Smoke Weed

The Tegridy Farms storyline, which spans multiple seasons, is satire at its best: equal parts critique of corporate cannabis, commentary on the commodification of wellness, and a portrait of midlife crisis. As Randy evolves into a weed mogul, South Park explores everything from THC-infused products to international cannabis trade.

For Parker and Stone, Tegridy Farms is more than a plot device—it’s a reflection of how far cannabis has come in mainstream America. In interviews, both creators have acknowledged they support legalization and view the war on drugs as a failure. “We always thought it was ridiculous,” Stone said in a 2020 interview. “People getting locked up for something safer than alcohol? It never made sense.”

The irony, of course, is that South Park itself has grown up with its audience. Millennials who watched the show in middle school are now adults—many with mortgages, careers, and legal weed in their states. The cannabis storylines, once rebellious, now resonate as social satire for a generation navigating late-stage capitalism and ever-shifting norms.

RELATED: The Science Behind Why Music Sounds So Much Better When You’re High